HRT FINANCIAL LP - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 439 filers reported holding REPLIGEN CORP in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
HRT FINANCIAL LP ownership history of REPLIGEN CORP
ValueSharesWeighting
Q2 2023$211
-73.7%
1,492
-68.7%
0.00%
-80.0%
Q1 2023$802
-100.0%
4,765
-73.7%
0.01%
-73.0%
Q3 2022$3,394,000
-76.9%
18,144
-67.3%
0.04%
-56.5%
Q4 2021$14,708,000
-19.4%
55,538
-12.0%
0.08%
-23.4%
Q3 2021$18,244,000
+240.9%
63,132
+45.8%
0.11%
-31.1%
Q2 2020$5,351,000
+93.0%
43,292
+44.4%
0.16%
+35.3%
Q4 2019$2,773,000
+780.3%
29,989
+629.1%
0.12%
+693.3%
Q3 2019$315,0004,1130.02%
Other shareholders
REPLIGEN CORP shareholders Q1 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders